Categories

行业新闻

由于糖尿病病例的增长,到2027年全球护理诊断市场将达到350亿美元

ByLabmedica Internationalstaff writers
2021年11月25日

Illustration

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.


此外,慢性病和传染病的患病率上升,例如心脏病,肝炎,癌症,胃肠道,呼吸道和性传播疾病(STD),正在推动护理诊断点市场。这些是估值报告的最新发现(印度班加罗尔),这是市场研究报告和行业分析的提供商。


An increase in the number of diabetic cases is expected to drive the growth of the point of care diagnostics market. The adoption of blood glucose monitoring systems is increasing due to factors such as the growing number of diabetic patients, increased patient knowledge of the importance of blood sugar monitoring, and the development of novel monitoring devices by important players. Other key factors likely to drive the growth of the point of care diagnostics market include the rising prevalence of other respiratory illnesses around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices through online platforms.


Point of care testing can significantly enhance the management of infectious diseases, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is lacking. Furthermore, government incentives and grants for the development of new products are accelerating the adoption of improved diagnostic technology for infectious diseases. People in undeveloped and developing countries can now afford these tests thanks to such initiatives. During the forecast period, factors such as the increasing number of clinics implementing point of care testing for the rapid identification of infectious diseases are expected to fuel market growth.


快速诊断中的纳米技术集成也有望推动护理诊断市场的增长。通过技术改进,至关重要的是,要实施高质量的医疗保健管理以快速患者护理。纳米技术使科学家可以研究广泛的医疗保健应用。通过基于纳米技术的护理诊断点的生产,将进一步提高产品需求。预计Covid-19爆发将进一步推动护理诊断市场的增长,因为越来越多的护理测试使用点可以快速诊断Covid-19。


根据类型,葡萄糖监测部门预计将是护理诊断市场中最有利可图的。在学术界和学术界,糖尿病患者人群的上升以及对家庭葡萄糖测试的偏爱越来越多的各个方面都促成了这一细分市场规模的所有方面。


Geographically, North America is expected to be the most lucrative region in the global point of care diagnostics market. With the rising incidence and prevalence of lifestyle diseases, the North American market is gaining traction. Furthermore, the presence of key players in the region, favorable government scenario, increased awareness of self-testing and home care products, and significant adoption of novel technologies are all expected to contribute significantly to the growth of the North American point of care diagnostics market.


Related Links:
评估报告



E-mail Print
FaceBook 推特 Google+ Linked in

Additional news

2022年7月27日
Medlab Asia and Asia Health to Host First-Ever Live, In-Person Event in Thailand
Informa Markets(英国伦敦)与Impact Muang Thong Thani(泰国非Thaburi)合作,已确认Medlab Asia和Asia Health将在泰国首次在泰国举行,当时共同确定的活动返回现场直播和面对面的事件。2022年10月19日至21日在曼谷的Impact展览中心。
Read More
25 Jul 2022
Registration Opens for RSNA 2022
现已开放北美放射学会(RSNA,OAK BROOK,IL,美国,美国)第108届科学大会和年度会议,将于2022年11月27日至12月1日在麦考密克广场芝加哥举行。
Read More
25 Jul 2022
Bioperfectus and ELITechGroup Collaborate for Monkeypox Virus Testing Across Europe
江苏Bioperfectus Technologies Co.,Ltd。(上海,中国)和Elitechgroup S.P.A.(法国普特亚(Puteaux,France))与整个欧洲的Monkeypox病毒测试建立了战略合作伙伴关系。
Read More
2022年7月20日
GE的医疗保健业务将被命名为GE Healthcare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
19 Jul 2022
Parker Labs与Tristel合作,用于高级超声探针消毒剂
Parker Laboratories Inc.(美国新泽西州Fairfield)和Tristel PLC(英国纽马克特)建立了商业合作伙伴关系,Tristel将在其中制造和分发其高级超声探针消毒剂。
Read More
14 Jul 2022
内窥镜设备的市场驱动到最低侵入性程序的增加驱动
全球内窥镜设备市场在2020年的价值为318亿美元,预计从2021年到2028年的复合年增长率为3.8%,这是由于在开放手术中的各种优势而造成的最低侵入性程序的增加驱动到。
Read More
11 Jul 2022
血气和电解质分析仪市场将由便携式/手持自动设备主导
全球血液和电解质分析仪市场预计将从2017年的17亿美元中获得9%的复合年增长率,到2026年,这是由于对便携式或手持自动分析师的偏爱而驱动到2026年的30亿美元。
Read More
08 Jul 2022
Meridian Bioscience Acquired by SD Biosensor and SJL Partners
Meridian Bioscience, Inc. (Cincinnati, OH, USA) and SD Biosensor, Inc. (Seoul, South Korea) and SJL Partners LLC (Seoul, South Korea) have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the consortium will acquire Meridian in an all-cash transaction valued at approximately USD 1.53 billion.
Read More
2022年6月27日
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
鉴于生活方式疾病的发生率越来越大,对负担得起的医疗保健的需求越来越多,使用机器人设备的有效手术会导致治疗成本下降,并推动全球机器人辅助手术器械(RASD)市场的增长。
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. |条款和条件